Literature DB >> 808229

Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.

S Ruddy, D T Fearon, K F Austen.   

Abstract

Two proteins in the properdin system, properdin and factor B, and complement components C4 and C3 were measured by radial immunodiffusion in serums and synovial fluids from 21 patients with rheumatoid arthritis (RA) and positive tests for rheumatoid factor, 9 patients with seronegative RA, and 10 with degenerative joint disease. In addition to depressions of synovial fluid C4 which correlated with lowered C3 in seropositive RA, consistent with activation of the classic pathway, low synovial fluid levels of factor B and properdin in seropositive RA indicate intraarticular activation of the properdin pathway as well.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808229     DOI: 10.1002/art.1780180401

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 2.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.

Authors:  V A Makinde; G Senaldi; A S Jawad; H Berry; D Vergani
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

Review 4.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

5.  Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis.

Authors:  H M Hanauske-Abel; B F Pontz; H U Schorlemmer
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

6.  Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

Authors:  P Woo; P J Lachmann; R A Harrison; N Amos; C Cooper; F S Rosen
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.

Authors:  B E Bourke; I K Moss; P Mumford; A Horsfall; R N Maini
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Metabolism of factor B of serum complement in rheumatoid arthritis.

Authors:  E H Krick; D H De Heer; R A Kaplan; C M Arroyave; J H Vaughan
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

10.  Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.

Authors:  M Doherty; N Richards; J Hornby; R Powell
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.